Insights from 2023 ASH Annual Meeting


 

ASH 2023 Insights: "Initial Results From the Summit Trial of Bezuclastinib in Adult Patients With Non-Advanced Systemic Mastocytosis"

20 views
December 21, 2023
0 Comments
Login to view comments. Click here to Login
Benign Hematology